Analyst ratings and price targets can significantly influence investor sentiment and stock prices. The reiteration of an Overweight rating and a high price target by Cantor Fitzgerald suggests a positive outlook for Intra-Cellular Therapies, which could lead to an increase in its stock price in the short term.